NEVVI Medicare utilization intelligence
or

← back

Provider profile

GRODIN, MICHAEL D.O.

Ophthalmology · NPI 1184670366 · LUTHERVILLE, MD

1
Groups
19
Codes · 2024
22,355
Disclosed services

GRODIN, MICHAEL is a Ophthalmology in LUTHERVILLE, MD, a member of 1 medical group, who billed 19 distinct codes to Medicare Part B in 2024.

Groups: KATZEN MEDICAL ASSOCIATES PC (LUTHERVILLE, MD)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

22,355
disclosed services
19
codes billed to Medicare Part B
Prior year · CY2023 18,154 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J2777 Injection, faricimab-svoa, 0.1 mg
92134 Imaging of retina
92235 Exam of retinal blood vessels using a special camera after injection of a dye
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J2781 Injection, pegcetacoplan, intravitreal, 1 mg
J0178 Injection, aflibercept, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
67028 Injection of drug into eye
J0177 Injection, aflibercept hd, 1 mg
92014 Established patient complete exam of visual system
J9035 Injection, bevacizumab, 10 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
66821 Removal of recurring cataract in lens capsule using a laser
67228 Destruction of leaking blood vessels of retina using laser
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
67210 Destruction of growth of retina using a laser
92083 Exam of visual field with extended testing
67220 Destruction of vascular growth between retina and sclera by photocoagulation
92201 Extended exam of the back part of the eye with retinal drawing

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.